• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码RNA在卵巢癌糖酵解中的作用

Noncoding RNAs in the Glycolysis of Ovarian Cancer.

作者信息

Zhang Chunmei, Liu Ning

机构信息

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

Front Pharmacol. 2022 Mar 30;13:855488. doi: 10.3389/fphar.2022.855488. eCollection 2022.

DOI:10.3389/fphar.2022.855488
PMID:35431949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9005897/
Abstract

Energy metabolism reprogramming is the characteristic feature of tumors. The tumorigenesis, metastasis, and drug resistance of ovarian cancer (OC) is dependent on energy metabolism. Even under adequate oxygen conditions, OC cells tend to convert glucose to lactate, and glycolysis can rapidly produce ATP to meet their metabolic energy needs. Non-coding RNAs (ncRNAs) interact directly with DNA, RNA, and proteins to function as an essential regulatory in gene expression and tumor pathology. Studies have shown that ncRNAs regulate the process of glycolysis by interacting with the predominant glycolysis enzyme and cellular signaling pathway, participating in tumorigenesis and progression. This review summarizes the mechanism of ncRNAs regulation in glycolysis in OC and investigates potential therapeutic targets.

摘要

能量代谢重编程是肿瘤的特征性表现。卵巢癌(OC)的肿瘤发生、转移和耐药性均依赖于能量代谢。即使在氧气充足的条件下,OC细胞也倾向于将葡萄糖转化为乳酸,糖酵解可快速产生ATP以满足其代谢能量需求。非编码RNA(ncRNAs)直接与DNA、RNA和蛋白质相互作用,在基因表达和肿瘤病理学中发挥重要的调控作用。研究表明,ncRNAs通过与主要的糖酵解酶和细胞信号通路相互作用来调节糖酵解过程,参与肿瘤的发生和发展。本文综述了ncRNAs在OC糖酵解中的调控机制,并探讨了潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/bffce6e4ce84/fphar-13-855488-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/08e92cb1adf2/fphar-13-855488-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/63672fdf4828/fphar-13-855488-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/b71440eeb9bd/fphar-13-855488-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/bfd56e68573a/fphar-13-855488-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/bffce6e4ce84/fphar-13-855488-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/08e92cb1adf2/fphar-13-855488-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/63672fdf4828/fphar-13-855488-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/b71440eeb9bd/fphar-13-855488-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/bfd56e68573a/fphar-13-855488-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/9005897/bffce6e4ce84/fphar-13-855488-g005.jpg

相似文献

1
Noncoding RNAs in the Glycolysis of Ovarian Cancer.非编码RNA在卵巢癌糖酵解中的作用
Front Pharmacol. 2022 Mar 30;13:855488. doi: 10.3389/fphar.2022.855488. eCollection 2022.
2
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.与乳腺癌葡萄糖代谢相关的非编码 RNA 的新兴调控作用。
Semin Cancer Biol. 2023 Oct;95:1-12. doi: 10.1016/j.semcancer.2023.06.007. Epub 2023 Jun 25.
3
Role of autophagy and its regulation by noncoding RNAs in ovarian cancer.自噬及其受非编码 RNA 调控在卵巢癌中的作用。
Exp Biol Med (Maywood). 2023 Jun;248(12):1001-1012. doi: 10.1177/15353702231151958. Epub 2023 Feb 18.
4
Non-coding RNAs in the reprogramming of glucose metabolism in cancer.非编码 RNA 在癌症葡萄糖代谢重编程中的作用。
Cancer Lett. 2018 Apr 10;419:167-174. doi: 10.1016/j.canlet.2018.01.048. Epub 2018 Jan 31.
5
Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.非编码 RNA:乳腺癌有氧糖酵解的关键调节因子。
Life Sci. 2020 Jun 1;250:117579. doi: 10.1016/j.lfs.2020.117579. Epub 2020 Mar 21.
6
Recent Advances in the Glycolytic Processes Linked to Tumor Metastasis.糖酵解过程与肿瘤转移相关的最新进展。
Curr Mol Pharmacol. 2024;17:e18761429308361. doi: 10.2174/0118761429308361240823061634.
7
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect.非编码RNA对癌症糖酵解的调控:开启瓦伯格效应
Mol Ther Oncolytics. 2020 Oct 10;19:218-239. doi: 10.1016/j.omto.2020.10.003. eCollection 2020 Dec 16.
8
Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244.长链非编码 RNA LINC00504 通过抑制 miR-1244 调节卵巢癌的瓦博格效应。
Mol Cell Biochem. 2020 Jan;464(1-2):39-50. doi: 10.1007/s11010-019-03647-z. Epub 2019 Nov 5.
9
Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review).长非编码 RNA 与 RNA 结合蛋白相互作用影响肿瘤糖代谢重编程的研究进展(综述)。
Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8365. Epub 2022 Jul 20.
10
Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.非编码RNA:肝细胞癌葡萄糖代谢的新兴调节因子
Am J Cancer Res. 2020 Dec 1;10(12):4066-4084. eCollection 2020.

引用本文的文献

1
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.卵巢癌中的长链非编码RNA:机制洞察与临床应用
Cancers (Basel). 2025 Jan 30;17(3):472. doi: 10.3390/cancers17030472.
2
Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key.癌症能量代谢和免疫微环境中与糖酵解相关的长非编码 RNA:一把神奇的钥匙。
Front Immunol. 2024 Sep 13;15:1456636. doi: 10.3389/fimmu.2024.1456636. eCollection 2024.
3
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities.

本文引用的文献

1
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations.小细胞肺癌的进展和转移:PI3K/Akt/mTOR 通路和代谢改变的作用。
Cancer Metastasis Rev. 2021 Dec;40(4):1141-1157. doi: 10.1007/s10555-021-10012-4. Epub 2021 Dec 27.
2
Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review.长链非编码 RNA:多发性硬化症中的新型罪犯或守护者:范围综述。
Front Immunol. 2021 Dec 7;12:774002. doi: 10.3389/fimmu.2021.774002. eCollection 2021.
3
Long Noncoding RNAs: Recent Insights into Their Role in Male Infertility and Their Potential as Biomarkers and Therapeutic Targets.
卵巢癌中的复杂肿瘤微环境:治疗挑战与机遇。
Curr Oncol. 2024 Jul 1;31(7):3826-3844. doi: 10.3390/curroncol31070283.
4
Infrared Spectroscopy in Gynecological Oncology: A Comprehensive Review of Diagnostic Potentials and Challenges.妇科肿瘤学中的红外光谱学:诊断潜力与挑战的综合综述。
Int J Mol Sci. 2024 May 30;25(11):5996. doi: 10.3390/ijms25115996.
5
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics.基于生物信息学分析乳酸代谢相关基因在卵巢癌中的预后价值。
J Ovarian Res. 2024 May 22;17(1):110. doi: 10.1186/s13048-024-01426-z.
6
Targeted Drug Nanodelivery and Immunotherapy for Combating Tumor Resistance.用于对抗肿瘤耐药性的靶向药物纳米递送与免疫疗法
Comb Chem High Throughput Screen. 2025;28(4):561-581. doi: 10.2174/0113862073296206240416060154.
7
CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention.环状 RNA 调控卵巢癌中的葡萄糖代谢:治疗干预的新领域。
Clin Transl Oncol. 2024 Mar;26(3):584-596. doi: 10.1007/s12094-023-03285-4. Epub 2023 Aug 14.
8
Role of microRNAs in glycolysis in gynecological tumors (Review).微小 RNA 在妇科肿瘤糖酵解中的作用(综述)。
Int J Oncol. 2023 May;62(5). doi: 10.3892/ijo.2023.5511. Epub 2023 Apr 13.
9
Advances in peptides encoded by non-coding RNAs: A cargo in exosome.非编码RNA编码的肽的研究进展:外泌体中的一种货物
Front Oncol. 2022 Dec 23;12:1081997. doi: 10.3389/fonc.2022.1081997. eCollection 2022.
10
Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis.肿瘤耐药的代谢信号通路研究趋势:一项科学计量学分析。
Front Oncol. 2022 Oct 25;12:981406. doi: 10.3389/fonc.2022.981406. eCollection 2022.
长链非编码 RNA:其在男性不育中的作用及作为生物标志物和治疗靶点的潜力的最新研究进展。
Int J Mol Sci. 2021 Dec 18;22(24):13579. doi: 10.3390/ijms222413579.
4
Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS.长链非编码 RNA 在前列腺癌和乳腺癌全基因组关联研究鉴定的染色体风险位点上的作用。
Genes (Basel). 2021 Dec 20;12(12):2028. doi: 10.3390/genes12122028.
5
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.微管干扰药物:在卵巢上皮癌治疗中的现状与未来作用
Cancers (Basel). 2021 Dec 12;13(24):6239. doi: 10.3390/cancers13246239.
6
Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.长链非编码RNA(lncRNAs)作为多发性骨髓瘤的预后和诊断生物标志物:一项系统综述和荟萃分析
Pathol Res Pract. 2022 Jan;229:153726. doi: 10.1016/j.prp.2021.153726. Epub 2021 Nov 29.
7
MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.肌成纤维细胞中的MyD88通过ERK依赖的PKM2核重新定位和激活来调节有氧糖酵解驱动的肝癌发生。
J Pathol. 2022 Apr;256(4):414-426. doi: 10.1002/path.5856. Epub 2022 Jan 27.
8
Targeting RAS in neuroblastoma: Is it possible?在神经母细胞瘤中靶向RAS:这可行吗?
Pharmacol Ther. 2022 Aug;236:108054. doi: 10.1016/j.pharmthera.2021.108054. Epub 2021 Dec 13.
9
GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure.GPR120 通过抑制 HK2 依赖性糖酵解诱导调节性树突状细胞,从而减轻暴发性肝衰竭。
Cell Death Dis. 2021 Dec 16;13(1):1. doi: 10.1038/s41419-021-04394-0.
10
Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis.糖酵解限速酶:类风湿关节炎发病机制的新潜在调节剂。
Front Immunol. 2021 Nov 24;12:779787. doi: 10.3389/fimmu.2021.779787. eCollection 2021.